Chemed Corporation $CHE Shares Sold by Corient Private Wealth LLC

Corient Private Wealth LLC lessened its position in Chemed Corporation (NYSE:CHE) by 24.4% during the fourth quarter, Holdings Channel reports. The institutional investor owned 4,211 shares of the company’s stock after selling 1,356 shares during the quarter. Corient Private Wealth LLC’s holdings in Chemed were worth $1,801,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. SG Americas Securities LLC increased its holdings in shares of Chemed by 773.5% in the fourth quarter. SG Americas Securities LLC now owns 26,466 shares of the company’s stock valued at $11,324,000 after buying an additional 23,436 shares in the last quarter. Intech Investment Management LLC bought a new stake in shares of Chemed during the 3rd quarter worth $1,429,000. BNP Paribas Financial Markets grew its holdings in shares of Chemed by 14.5% in the 4th quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company’s stock worth $14,985,000 after acquiring an additional 4,430 shares during the last quarter. Bahl & Gaynor Inc. grew its holdings in shares of Chemed by 15.4% in the 3rd quarter. Bahl & Gaynor Inc. now owns 20,042 shares of the company’s stock worth $8,974,000 after acquiring an additional 2,673 shares during the last quarter. Finally, Abacus FCF Advisors LLC acquired a new stake in shares of Chemed during the fourth quarter worth $5,935,000. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Transactions at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the transaction, the chief executive officer owned 90,219 shares in the company, valued at $37,993,927.47. This represents a 2.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Andrea R. Lindell sold 1,347 shares of the company’s stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the transaction, the director owned 4,578 shares in the company, valued at $2,047,876.74. This represents a 22.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 3.33% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on CHE shares. Weiss Ratings raised Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th. Royal Bank Of Canada upped their price objective on shares of Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research note on Monday, April 27th. Finally, Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Two research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $501.50.

Chemed Price Performance

Shares of NYSE:CHE opened at $459.36 on Tuesday. The company’s fifty day moving average is $427.95 and its two-hundred day moving average is $425.32. The company has a market cap of $6.10 billion, a P/E ratio of 25.03, a price-to-earnings-growth ratio of 1.74 and a beta of 0.54. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $508.70. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11.

Chemed (NYSE:CHE) last issued its earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, topping the consensus estimate of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The business had revenue of $657.51 million during the quarter, compared to analysts’ expectations of $659.22 million. During the same quarter last year, the firm posted $5.63 earnings per share. Chemed’s revenue was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Equities analysts expect that Chemed Corporation will post 22.3 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were paid a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend was Thursday, May 28th. Chemed’s dividend payout ratio is currently 13.08%.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.